A significant body of study reveals distinct differences between cancer treatment systems in the America and Continental Europe. While both regions strive to enhance patient's outcomes, strategies to identification, therapy, and monitoring can vary widely. For case, the American often relies a more fragmented system, potentially leading to faster d